N-Coumaroyldopamine and N-caffeoyldopamine increase cAMP via beta 2-adrenoceptors in myelocytic U937 cells

被引:29
作者
Park, JB [1 ]
机构
[1] ARS, Phytonutrients Lab, BHNRC, USDA, Beltsville, MD 20705 USA
关键词
phytochemical; cardiac disease; beta-adrenoceptor agonist; cocoa;
D O I
10.1096/fj.04-2782com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-Caffeoyldopamine is a phytochemical found in various plants, including cocoa (Theobroma cacao L.). N-caffeoyldopamine and its natural analogs (N-cinnamoyldopamine, N-coumaroyldopamine, N-feruloyldopamine, and N-sinapoyldopamine) were synthesized and investigated to determine their potency as P-adrenoceptor agonists, because they have chemical structural moieties found in P-adrenoceptor agonists. Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations <0.05 mu M in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N-caffeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine. Using beta 2-specific antagonists (butoxamine and ICI 118551), N-coumaroyldopamine and N-caffeoyldopamine were found to increase cAMP via beta 2-adrenoceptors in U937 cells. In producing cAMP in U937 cells, N-coumaroyldopamine and N-caffeoyldopamine were as potent as several well-known beta 2-adrenoceptor agonists (salbutamol, procaterol, and fenoterol). These results indicate that N-coumaroyldopamine and N-caffeoyldopamine are potent compounds able to increase cAMP via beta 2-adrenoceptors in U937 cells, and may have potential effects on human health.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 43 条
[1]  
Albericio F, 1997, METHOD ENZYMOL, V289, P104
[2]   Localization and identification of phenolic compounds in Theobroma cacao L. somatic embryogenesis [J].
Alemanno, L ;
Ramos, T ;
Gargadenec, A ;
Andary, C ;
Ferriere, N .
ANNALS OF BOTANY, 2003, 92 (04) :613-623
[3]   Thermogenic drugs as a strategy for treatment of obesity [J].
Astrup, A .
ENDOCRINE, 2000, 13 (02) :207-212
[4]   Cloning and characterization of a hydroxycinnamoyl-CoA :tyramine N-(hydroxycinnamoyl)transferase induced in response to UV-C and wounding from Capsicum annuum [J].
Back, K ;
Jang, SM ;
Lee, BC ;
Schmidt, A ;
Strack, D ;
Kim, KM .
PLANT AND CELL PHYSIOLOGY, 2001, 42 (05) :475-481
[5]   α1-adrenoceptor antagonists.: 4.: Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives [J].
Betti, L ;
Botta, M ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3603-3611
[6]   Pharmacological characteristics of Ro 115-1240, a selective α1A/1L-adrenoceptor partial agonist:: a potential therapy for stress urinary incontinence [J].
Blue, DR ;
Daniels, DV ;
Gever, JR ;
Jett, MF ;
O'Yang, C ;
Tang, HM ;
Williams, TJ ;
Ford, APDW .
BJU INTERNATIONAL, 2004, 93 (01) :162-170
[7]  
Bradberry J Chris, 2004, J Am Pharm Assoc (2003), V44, pS37, DOI 10.1331/154434504322904596
[8]   ISOPRENALINE INHIBITS THROMBOXANE-B2 RELEASE FROM U937 CELLS [J].
BRIGHTLING, CE ;
BAKER, AJ ;
FULLER, RW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 53 (05) :559-562
[9]   Alpha-adrenoceptor subtypes [J].
Calzada, BC ;
De Artiñano, AA .
PHARMACOLOGICAL RESEARCH, 2001, 44 (03) :195-208
[10]  
Cheer Susan M, 2002, Am J Respir Med, V1, P285